Novartis gets European nod for once-daily bronchodilator Onbrez Breezhaler
Novartis announced that the European Commission (EC) has approved Onbrez Breezhaler (QAB149 or indacaterol) in both 150 mcg and 300 mcg doses as a new once-daily maintenance bronchodilator ...
PharmaBiz,
Fri Dec 04 19:51:25 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News